Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology | Gastroenterology | Family Medicine
Nephropathy Clinical Trials
A listing of Nephropathy medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 Last
Alabama
Site Reference ID/Investigator# 105317
Birmingham Alabama 35211
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
California
Site Reference ID/Investigator# 99948
Alhambra California 91801
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96605
Azusa California 91702
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 99975
Chula Vista California 91911
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96591
Chula Vista California 91910
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 105566
Downey California 90241
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
View More »
Site Reference ID/Investigator# 96597
La Mesa California 91942
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 99397
Los Angeles California 90036
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96596
Los Angeles California 90022
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96704
Mission Hills California 91345
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 105199
Norwalk California 90650
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96702
Palm Springs California 92262
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 104900
Sacramento California 95825
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 105316
San Diego California 92123
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96640
Santa Barbara California 93110
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Florida
Site Reference ID/Investigator# 99897
Kissimmee Florida 34741
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96623
Pembroke Pines Florida 33028
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96606
West Palm Beach Florida 33401
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Georgia
Site Reference ID/Investigator# 107999
Decatur Georgia 30030
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 105177
Dunwoody Georgia 30338
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 105155
Suwanee Georgia 30024
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Hawaii
Site Reference ID/Investigator# 96598
Honolulu Hawaii 96814
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Illinois
Site Reference ID/Investigator# 96588
Chicago Illinois 60616
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Louisiana
Ochsner Medical Center
New Orleans Louisiana 70121
A clinical research study of intravenous NAC and Placebo for the treatment of Nephropathy
Maryland
Site Reference ID/Investigator# 96610
Baltimore Maryland 21204
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96590
Rockville Maryland 20852
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Massachusetts
Site Reference ID/Investigator# 96637
Holyoke Massachusetts 01040
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 99946
Plymouth Massachusetts 02360
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Michigan
Site Reference ID/Investigator# 105176
Flint Michigan 48504
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96613
Flint Michigan 48503
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Nevada
Site Reference ID/Investigator# 104910
Reno Nevada 89511
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
New Jersey
Site Reference ID/Investigator# 103995
Eatontown New Jersey 07724
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
New York
View More »
Site Reference ID/Investigator# 96592
Albany New York 12206
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96604
New Hyde Park New York 11042
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 107215
New York New York 10001
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 105235
New York New York 10128
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96603
Orchard Park New York 14220
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
North Carolina
Site Reference ID/Investigator# 96638
Charlotte North Carolina 28207
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 99898
Morehead City North Carolina 28557
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 100876
New Bern North Carolina 28562
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96602
Winston-Salem North Carolina 27103
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Pennsylvania
Site Reference ID/Investigator# 96607
Bethlehem Pennsylvania 18017
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 105516
Pittsburgh Pennsylvania 15243
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
South Carolina
Site Reference ID/Investigator# 105175
Columbia South Carolina 29203
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 107197
Myrtle Beach South Carolina 29572
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96612
Orangeburg South Carolina 29118
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Texas
Site Reference ID/Investigator# 99896
Houston Texas 77004
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 96608
McAllen Texas 78503
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
Site Reference ID/Investigator# 104913
San Antonio Texas 78224
A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy
First 1 2 Last